Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.1 (
adenylate cyclase
)
19,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acidic phospholipids play a critical role in the hormone activation of
adenylate cyclase
. Solubilized myocardial
adenylate cyclase
is unresponsive to glucagon and the catecholamines, two of the hormones which activate the membrane-bound enzyme.
Phosphatidylserine
, purified from bovine brain restored glucagon responsiveness of the solubilized
adenylate cyclase
. Monophosphatidylinositol, also purified from bovine brain, restored catecholamine responsiveness. Solubilized preparations of myocardial
adenylate cyclase
bind 125-I-glucagon either in the presence of added phosphatidylserine, thereby providing a clear separation of the processes of activation and binding. Solubilized myocardial
adenylate cyclase
has a molecular weight of about 160,000. Sephadex G-100 chromatography of the solubilized enzyme following the binding of 125-I-glucagon to its myocardial receptor reveals two distinct peaks; one, having catalytic activity and a molecular weight greater than 100,000 and two, the binding material having no catalytic activity and a molecular weight of 24,000-28,000. These data are consistent with the presence of a dissociable glucagon receptor site. The role of this dissociation in the activation-inactivation of the enzyme remains to be explored. It is postulated that phospholipids induce the required configurational change in the catalytic site following the binding of hormone to its receptor, and by this means couples the receptor to the catalytic site. This model may be applicable to certain clinical situations. Cardiac
adenylate cyclase
is unresponsive to glucagon in chronic congestive heart failure. The defect may reside either in the binding of glucagon to its receptor site or in the metabolism of a specific acidic phospholipid such as phosphatidylserine.
...
PMID:The glucagon receptor and adenylate cyclase. 16 52
Phosphatidylserine
vesicles incubated in hypotonic conditions with rat brain synaptosomes increased basal
adenylate cyclase
activity but did not modify the response of the enzyme to norepinephrine. Moreover, phosphatidylserine antagonized the stimulation of
adenylate cyclase
activity by NaF. We suggest that in present experimental conditions the effect of phosphatidylserine vesicles is at the level of the GS regulatory protein of
adenylate cyclase
.
...
PMID:Phosphatidylserine vesicles increase rat brain synaptosomal adenylate cyclase activity. 359 57
We have recently described the preparation of a solubilized cat myocardial
adenylate cyclase
which is unresponsive to histamine, norepinephrine, glucagon, and thyroxine, the hormones which activate the particulate enzyme. Since hormone receptors may consist of proteins and phospholipids, we determined the effect of several phospholipids on restoring the responsiveness of the solubilized
adenylate cyclase
to histamine. The addition of phosphatidylserine completely restored the histamine-mediated activation of the solubilized enzyme in contrast to phosphatidylethanolamine and phosphatidylinositol which were without effect. The concentration of histamine producing half-maximal activation of
adenylate cyclase
, 2 x 10(-5) M, was virtually identical with that observed in the particulate preparation. The antihistamine, diphenhydramine, 8 x 10(-5) M, abolished activation of
adenylate cyclase
by histamine in both the solubilized and particulate preparations.
Phosphatidylserine
also restored glucagon responsiveness, but did not restore norepinephrine responsiveness. It would appear that phosphatidylserine produced the necessary molecular configuration of the
adenylate cyclase
for histamine binding and activation of the enzyme.
...
PMID:Solubilized myocardial adenylate cyclase. Restoration of histamine responsiveness by phosphatidylserine. 433 44
Treatment of striatal washed particles with phospholipase A(2) or C abolished the activation of
adenylate cyclase
by dopamine but not by N(16)-phenylisopropyl adenosine (PIA). The inhibition of dopamine-sensitive cyclase was dependent on Ca2+ and increased with time and phospholipase concentration. F(-)-sensitive cyclase was not affected by phospholipase A(2) treatment, but was enhanced by phospholipase C treatment. Phospholipase D did not affect basal, PIA, dopamine, or F(-)-sensitive cyclase activities. The observed effects of phospholipase A(2) were not due to either the detergent effect of lysophospholipids or to contaminating proteases. Dopamine-sensitive cyclase, inactivated by pretreatment with phospholipase A(2), was restored by asolectin (a soybean mixed phospholipid), phosphatidylcholine, phosphatidylethanolamine, or phosphatidylserine, but not by phosphatidylinositol.
Phosphatidylserine
and phosphatidylcholine were equipotent in restoring dopamine-sensitive activity. Lubrol-PX, a nonionic detergent, abolished completely the dopamine-sensitive cyclase activity, whereas PIA-sensitive activity was slightly inhibited. In contrast, digitonin inhibited dopamine- and PIA-sensitive cyclase activity in a parallel fashion. Lubrol-PX released some
adenylate cyclase
into a 16,000 x g supernatant fraction that was stimulated by PIA but not by dopamine. Removal of most of the free detergent by Bio-bead SM 2 enhanced stimulation by PIA but did not restore sensitive cyclase. The data suggest that the requirement for phospholipids for the coupling of dopamine and adenosine receptors to the striatal
adenylate cyclase
may be different and that the adenosine receptors may be more tightly coupled to the enzyme than are dopamine receptors.
...
PMID:Role of phospholipids in coupling of adenosine and dopamine receptors to striatal adenylate cyclase. 626 36
Phosphatidylserine
(PS), phosphatidylinositol (PIN) or phosphatidylglycerol (PGL) incubated with synaptosomal plasma membranes (SPM) of dog brain, stimulated
adenylate cyclase
. The enzyme activity showed a dramatic increase at around 1.6 mumol PS/mg protein, while use of higher concentrations led to inhibition of the activity with respect to the maximal percentage of stimulation. Moreover, PS stimulated the dopamine-sensitive
adenylate cyclase
. Solubilization of SPM by the detergent Lubrol-PX did not affect the enzyme activation induced by dopamine. The solubilization, also, showed that the enzyme activity does not change at any PS, PIN or PGL concentration used. These results indicate that acidic phospholipids do not directly act on
adenylate cyclase
, but indirectly, affecting the membrane fluidity probably. Such modifications of interactions through lipid-protein(s) of
adenylate cyclase
may have implications to physiological responses to hormones or/and neurotransmitters in the central nervous system.
...
PMID:Stimulation of brain synaptosome-associated adenylate cyclase by acidic phospholipids. 653 49